(106 days)
Not Found
Not Found
No
The summary describes a manually operated imaging device for brachytherapy localization and simulation, with no mention of AI, ML, or automated image processing beyond basic visualization.
No
The device is described as a localization and simulation device for brachytherapy treatments, intended for visualizing and confirming radiation fields. It does not deliver therapy itself but aids in the planning and confirmation process.
No
Explanation: The device is described as a "localization and simulation device" for radiation therapy. Its intended use is for "visualization, localization and confirmation of the volume and size of the Brachy radiation therapy irradiation field(s)," which is part of treatment planning and execution, not diagnosing a medical condition.
No
The device description clearly outlines physical hardware components including a gantry, L-arm, C-arm, X-Ray tube housing assembly, collimator, image intensifier, and a mobile patient couch. This indicates it is a hardware device, not software-only.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are medical devices used to examine specimens taken from the human body (like blood, urine, or tissue) to provide information for diagnosis, monitoring, or screening.
- Device Function: The Integrated Brachytherapy Unit (IBU) is described as a localization and simulation device for radiation therapy. It uses X-ray imaging to visualize and confirm the radiation field within the patient's body.
- Lack of Specimen Analysis: The description does not mention the analysis of any biological specimens. The device interacts directly with the patient for imaging purposes.
Therefore, the IBU falls under the category of a medical imaging device used for treatment planning and verification, not an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
The IBU is intended to be used for the visualization, localization and confirmation of the volume and size of the Brachy therapy irradiation field(s), using a fluoroscopic and/or radiographic system.
The Integrated Brachytherapy Unit (IBU) is intended to be used for the visualization, localization and confirmation of the volume and size of the Brachy radiation therapy irradiation field(s), using a fluoroscopic and/or radiographic system. Localization and simulation for Brachy radiation therapy can be performed more effectively on the IBU than on a standard radiation treatment simulator. The additional L-arm allows the user to visualize under many angles easier for the operator than with the predicate device. The IBU will not be used for the simulation of external beam radiation treatments.
Product codes (comma separated list FDA assigned to the subject device)
90 KPQ
Device Description
The IBU integrated Brachy therapy imaging unit is a localization and simulation device for a radiation therapy department especially for Brachy therapy treatments. It consists of a gantry that supports an L-arm and a C-arm which can rotate isocentrically. The C-arm houses an X-Ray tube housing assembly with collimator on one side and an image intensifier with optional rotatable cassette holder. The movements of the IBU are manually driven, after the relevant electrical locks are lifted. The mobile IBU patient couch has mechanical motions which can be controlled from a hand pendant affixed to the table.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
fluoroscopic and/or radiographic system.
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
radiation therapy department
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Not Found
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.5840 Radiation therapy simulation system.
(a)
Identification. A radiation therapy simulation system is a fluoroscopic or radiographic x-ray system intended for use in localizing the volume to be exposed during radiation therapy and confirming the position and size of the therapeutic irradiation field produced. This generic type of device may include signal analysis and display equipment, patient and equipment supports, treatment planning computer programs, component parts, and accessories.(b)
Classification. Class II.
0
Premarket Notification Nucletron IBU Date :29 August 1997
JAN 2 2 1998
Image /page/0/Picture/2 description: The image shows the word "Nucletron" in a bold, sans-serif font. To the left of the word is a square logo. The logo contains a black circle with two white circles on opposite sides of the black circle. The logo and the word "Nucletron" are both in black.
Department of Health and Human Services Center of Devices and Radiological Health Office of Device Evaluation Pre-Market Notification section
NUCLETRON B.V.
Waardgelder 1 3905 TH Veenendaal 3900 AX Veenendaal P.O.Box 930 The Netherlands Phone +31 318 557133 Fax +31 318 550485
FBN MKT IBU 510K 70819.4.doc 29 August 1997
510(K) SUMMARY OF SAFETY AND EFFECTIVENESS INFORMATION
as required by section 807.92(c)
Submitter of 510(k) a.
Company name: Registration # Address:
Nucletron Corporation 1121753 7080 Columbia Gateway Drive Columbia, MD 21046-2133
Contact Person:
Ralph E. Shuping Requlatory Affairs Manager 410-312-4100 Phone:. 410-312-4197 Fax:
Device Name: b.
Trade/Proprietary Name: Common/Usual Name: Classification Name:
IBU. Integrated Brachy therapy Unit Image-intensified fluoroscopic RT simulation system Radiation therapy simulation system, 21 CFR 892.5840 Class II.
Legally Marketed Predicate Device(s) C.
Our Device is substantially equivalent to the legally marketed predicate devices cited in the table below.
| Manufacturer | Device |
|---|---|
| Nucletron | Simulix-HP |
| Philips | Integris |
.
1
Premarket Notification
Nucletron IBU
Date :29 August 1997
Description d. .
The IBU integrated Brachy therapy imaging unit is a localization and simulation device for a radiation therapy department especially for Brachy therapy treatments. It consists of a gantry that supports an L-arm and a C-arm which can rotate isocentrically. The C-arm houses an X-Ray tube housing assembly with collimator on one side and an image intensifier with optional rotatable cassette holder. The movements of the IBU are manually driven, after the relevant electrical locks are lifted. The mobile IBU patient couch has mechanical motions which can be controlled from a hand pendant affixed to the table.
Intended use e.
The IBU is intended to be used for the visualization, localization and confirmation of the volume and size of the Brachy therapy irradiation field(s), using a fluoroscopic and/or radiographic system.
Summary of technological considerations f.
The IBU is substantially equivalent to the predicate devices. It allows visualization of volumes to be irradiated under a variety of angles. The IBU uses X-Ray imaging for diagnostic and treatment planning purposes, where by the patient is supported by a patient table which can be moved vertical, lateral and longitudinal to position the relevant anatomy in the isocenter for visualization.
To optimize the use for Brachy therapy simulation. The IBU has a mobile table operated from internal batteries, so that the patient could possibly be prepared in a separate room.
Standards ਹੈ
The IBU system is subject to Federal Performance standard 21 CFR 1020.30. The IBU system will be manufactured in accordance with voluntary safety standards, such as UL 187 and IEC 601;
Talvini
28 Aug '97
Date
Name Frank de Bruin Product Manager Simulation products Title Nucletron bv Veenendaal Netherlands
2
Image /page/2/Picture/0 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle with three curved lines representing its body and wings. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" are arranged in a circular pattern around the eagle.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JAN 22 1998
Ralph Shuping, Sc.D. Regulatory Affairs Manager Nucletron Corporation 7080 Columbia Gateway Drive Columbia, MD 21046-2133
Re:
K973848 IBU, Integrated Brachy Therapy Unit Dated: October 6, 1997 Received: October 8, 1997 Regulatory class: II 21 CFR 892.5840/Procode: 90 KPQ
Dear Mr. Shuping:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the intenstated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Devices that have been reclassified in accordance with the provisions of the Federal Food; Drug; and Cosmetic Act (Act); You may; therefore; market the device; subject ' to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under Radiation Control provisions, or other Federal laws or regulations.
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4613. Additionally, for question and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsmamain.html".
Sincerely yours
h7liau Yu
Lillian Yin, Ph.D.
Director, Division of Reproductive, Abdominal, Ear, Nose and Throat, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
3
Statement of indications for use
510(k) Number (if known): __ K 9 7 3 8 4 8
Device Name: IBU (Integrated Brachytherapy Unit)
Indications for Use: The Integrated Brachytherapy Unit (IBU) is intended to be used for the visualization, localization and confirmation of the volume and size of the Brachy radiation therapy irradiation field(s), using a fluoroscopic and/or radiographic system. Localization and simulation for Brachy radiation therapy can be performed more effectively on the IBU than on a standard radiation treatment simulator. The additional L-arm allows the user to visualize under many angles easier for the operator than with the predicate device. The IBU will not be used for the simulation of external beam radiation treatments.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
| Prescription Use | ✓ | OR | Over the Counter Use | |
|---|---|---|---|---|
| (Per 21 CFR 801.109) |
| (Optional Format 1-2-96) | |
|---|---|
| -- | -------------------------- |
(Division Sign-Off)
Division of Reproductive, Abdominal, ENT,
and Radiological Devices
510(k) Number